Literature DB >> 7628016

A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency.

B Schmidt1, T Selmer, A Ingendoh, K von Figura.   

Abstract

Multiple sulfatase deficiency (MSD) is a lysosomal storage disorder characterized by a decreased activity of all known sulfatases. The deficiency of sulfatases was proposed to result from the lack of a co- or posttranslational modification that is common to all sulfatases and required for their catalytic activity. Structural analysis of two catalytically active sulfatases revealed that a cysteine residue that is predicted from the cDNA sequence and conserved among all known sulfatases is replaced by a 2-amino-3-oxopropionic acid residue, while in sulfatases derived from MSD cells, this cysteine residue is retained. It is proposed that the co- or posttranslational conversion of a cysteine to 2-amino-3-oxopropionic acid is required for generating catalytically active sulfatases and that deficiency of this protein modification is the cause of MSD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628016     DOI: 10.1016/0092-8674(95)90314-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  84 in total

1.  Escherichia coli K1 aslA contributes to invasion of brain microvascular endothelial cells in vitro and in vivo.

Authors:  J A Hoffman; J L Badger; Y Zhang; S H Huang; K S Kim
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  A consensus mechanism for Radical SAM-dependent dehydrogenation? BtrN contains two [4Fe-4S] clusters.

Authors:  Tyler L Grove; Jessica H Ahlum; Priya Sharma; Carsten Krebs; Squire J Booker
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

3.  Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum.

Authors:  T Dierks; B Schmidt; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.

Authors:  T Litjens; D A Brooks; C Peters; G J Gibson; J J Hopwood
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

5.  X-ray structure of an AdoMet radical activase reveals an anaerobic solution for formylglycine posttranslational modification.

Authors:  Peter J Goldman; Tyler L Grove; Lauren A Sites; Martin I McLaughlin; Squire J Booker; Catherine L Drennan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

6.  An efficient, multiply promiscuous hydrolase in the alkaline phosphatase superfamily.

Authors:  Bert van Loo; Stefanie Jonas; Ann C Babtie; Alhosna Benjdia; Olivier Berteau; Marko Hyvönen; Florian Hollfelder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

7.  SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Eva Charlotte Ennemann; Karthikeyan Radhakrishnan; Bernhard Schmidt; Anupam Chakrapani; Hans-Jürgen Christen; Hugo Moser; Beat Steinmann; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

Review 8.  Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria.

Authors:  Shumin Wang; Kazuyuki Sugahara; Fuchuan Li
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

Review 9.  A review of coumarin derivatives in pharmacotherapy of breast cancer.

Authors:  Musiliyu A Musa; John S Cooperwood; M Omar F Khan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Sulfatase modifying factor 1-mediated fibroblast growth factor signaling primes hematopoietic multilineage development.

Authors:  Mario Buono; Ilaria Visigalli; Roberta Bergamasco; Alessandra Biffi; Maria Pia Cosma
Journal:  J Exp Med       Date:  2010-07-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.